Compare Arisinfra Solu. with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 1.23%
- The company has been able to generate a Return on Equity (avg) of 1.23% signifying low profitability per unit of shareholders funds
Low ability to service debt as the company has a high Debt to EBITDA ratio of 0.70 times
Healthy long term growth as Operating profit has grown by an annual rate 371.95%
With a growth in Net Sales of 26.78%, the company declared Very Positive results in Mar 26
With ROE of 7.4, it has a Very Attractive valuation with a 1.3 Price to Book Value
Stock DNA
Trading & Distributors
INR 965 Cr (Micro Cap)
17.00
23
0.00%
-0.07
7.42%
1.31
Total Returns (Price + Dividend) 
Arisinfra Solu. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Arisinfra Solutions Ltd is Rated Buy by MarketsMOJO
Arisinfra Solutions Ltd is rated Buy by MarketsMOJO, with this rating last updated on 15 Jun 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 June 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Arisinfra Solutions Ltd Technical Momentum Shifts Amid Mixed Market Signals
Arisinfra Solutions Ltd, a micro-cap player in the Trading & Distributors sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend. Despite a recent downgrade in daily moving averages and a 3.66% drop in share price, the company’s weekly and monthly technical indicators present a nuanced picture, reflecting both resilience and caution for investors navigating volatile market conditions.
Read full news article
Arisinfra Solutions Ltd Sees Technical Momentum Shift Amid Mixed Returns
Arisinfra Solutions Ltd, a micro-cap player in the Trading & Distributors sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a 4.14% gain in the stock price on 16 Jun 2026, signalling renewed investor interest despite mixed returns over recent periods.
Read full news article Announcements 
Closure of Trading Window
24-Jun-2026 | Source : BSEClosure of Trading Window for the Quarter Ended June 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
23-Jun-2026 | Source : BSEThis is to intimate that the NRC has through the circular resolution passed today i.e June 23 2026 approved the allotment of 32 600 equity shares of the company .
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
12-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shivanand Shankar Mankekar HUF & PACs
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 8 FIIs (2.08%)
Aspire Family Trust (jasmine Bhaskar Shah) (8.72%)
Neomile Growth Fund - Series I (5.72%)
36.97%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 26.78% vs 12.29% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 29.84% vs 6.93% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Nine Monthly Results Snapshot (Standalone) - Dec'25
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 39.05% vs 10.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 2,445.89% vs 111.12% in Mar 2025






